| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10972711 | International Journal for Parasitology | 2012 | 6 Pages |
Abstract
⺠Current strategy for treatment of clinical disease relies on species- and stage-specific therapies guided by diagnosis. ⺠This strategy derives from two historic biases favouring management of malaria in travellers. ⺠Elimination therapy means attacking all species and stages regardless of diagnostic outcome or availability. ⺠Hemolytic toxicity of primaquine in G6PDd patients is the primary impediment to therapies for managing endemic malarias. ⺠A research agenda for optimising primaquine therapy when combined with modern antimalarials is needed.
Related Topics
Life Sciences
Immunology and Microbiology
Parasitology
Authors
J. Kevin Baird,